Postmarketing surveillance for drug abuse

被引：31

作者：

Arfken, CL

Cicero, TJ

机构：

[1] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA

[2] Washington Univ, Sch Med, St Louis, MO USA

来源：

DRUG AND ALCOHOL DEPENDENCE | 2003年 / 70卷 / 03期

关键词：

abuse liability; postmarketing surveillance; prescription medications;

D O I：

10.1016/S0376-8716(03)00102-9

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

Assessing actual abuse of prescribed medications requires postmarketing surveillance. In this article we discuss general systems of postmarketing surveillance that exist as of the end of 2002 in the United States and two medication-specific surveillance systems that were devised and tested. The two specific surveillance systems are compared with limitations highlighted. Postmarketing surveillance is in its infancy and requires more research on ways to improve its validity without inducing illicit experimentation. Information on comparator medications is highly recommended both to validate the system and to place the results in context. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.

引用

收藏

页码：S97 / S105

页数：9

相关论文

共 16 条

[1]

AREND I, 1978, ARZNEIMITTEL-FORSCH, V28-1, P199

[2] Postmarketing surveillance of abuse liability of sibutramine [J].

Arfken, CL ;

Schuster, CR ;

Johanson, CE .

DRUG AND ALCOHOL DEPENDENCE, 2003, 69 (02) :169-173

[3] Principles of drug abuse liability assessment in laboratory animals [J].

Ator, NA ;

Griffiths, RR .

DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (03) :S55-S72

[4] Assessing abuse liability in clinical trials [J].

Brady, KT ;

Lydiard, RB ;

Brady, JV .

DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (03) :S87-S95

[5] THE PHARMACOLOGY OF SIBUTRAMINE HYDROCHLORIDE (BTS54524), A NEW ANTIDEPRESSANT WHICH INDUCES RAPID NORADRENERGIC DOWN-REGULATION [J].

BUCKETT, WR ;

THOMAS, PC ;

LUSCOMBE, GP .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1988, 12 (05) :575-584

[6] A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United States [J].

Cicero, TJ ;

Adams, EH ;

Geller, A ;

Inciardi, JA ;

Muñoz, A ;

Schnoll, SH ;

Senay, EC ;

Woody, GE .

DRUG AND ALCOHOL DEPENDENCE, 1999, 57 (01) :7-22

[7] Principles of initial experimental drug abuse liability assessment in humans [J].

Griffiths, RR ;

Bigelow, GE ;

Ator, NA .

DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (03) :S41-S54

[8] A COMPARISON OF THE EFFECTS OF SIBUTRAMINE HYDROCHLORIDE, BUPROPION AND METHAMPHETAMINE ON DOPAMINERGIC FUNCTION - EVIDENCE THAT DOPAMINE IS NOT A PHARMACOLOGICAL TARGET FOR SIBUTRAMINE [J].

HEAL, DJ ;

FRANKLAND, ATJ ;

GOSDEN, J ;

HUTCHINS, LJ ;

PROW, MR ;

LUSCOMBE, GP ;

BUCKETT, WR .

PSYCHOPHARMACOLOGY, 1992, 107 (2-3) :303-309

[9] INTRODUCING MEDWATCH - A NEW APPROACH TO REPORTING MEDICATION AND DEVICE ADVERSE-EFFECTS AND PRODUCT PROBLEMS [J].

KESSLER, DA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (21) :2765-2768

[10]

KEUP W, 1993, MISSBRAUNSCHSMUSTER